相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
Tata Nageswara Rao et al.
BLOOD (2019)
Over-expression of a retinol dehydrogenase (SRP35/DHRS7C) in skeletal muscle activates mTORC2, enhances glucose metabolism and muscle performance
Alexis Ruiz et al.
SCIENTIFIC REPORTS (2018)
Hypoxia Inducible Factor (HIF) transcription factor family expansion, diversification, divergence and selection in eukaryotes
Allie M. Graham et al.
PLOS ONE (2017)
Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates
Sahrish Shah et al.
BLOOD CANCER JOURNAL (2017)
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
Ruben A. Mesa et al.
LANCET HAEMATOLOGY (2017)
Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
Luisa Iommarini et al.
FRONTIERS IN ONCOLOGY (2017)
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
Prithviraj Bose et al.
BLOOD (2017)
JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation
J. S. Ahn et al.
ONCOGENE (2016)
Adult hematopoietic stem cells lacking Hif-1α self-renew normally
Milica Vukovic et al.
BLOOD (2016)
Drugging the addict: non-oncogene addiction as a target for cancer therapy
Remco Nagel et al.
EMBO REPORTS (2016)
Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
Hong-Sheng Zhou et al.
CANCER BIOLOGY & MEDICINE (2016)
Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway
Vladan P. Cokic et al.
PLOS ONE (2015)
Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells
Paulina Kucharzewska et al.
PLOS ONE (2015)
Hypoxia-inducible factors in cancer stem cells and inflammation
Gong Peng et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Bortezomib attenuates HIF-1-but not HIF-2-mediated transcriptional activation
Noraini Abd-Aziz et al.
ONCOLOGY LETTERS (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells
Yin Wang et al.
BLOOD (2014)
Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells
Toru Mitsumori et al.
EXPERIMENTAL HEMATOLOGY (2014)
Concise Review: Genetic Dissection of Hypoxia Signaling Pathways in Normal and Leukemic Stem Cells
Deniz Gezer et al.
STEM CELLS (2014)
The role of PHD2 mutations in the pathogenesis of erythrocytosis
Betty Gardie et al.
HYPOXIA (2014)
Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance
Amelie V. Guitart et al.
BLOOD (2013)
A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
C. Marty et al.
LEUKEMIA (2013)
Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment
Cesar Nombela-Arrieta et al.
NATURE CELL BIOLOGY (2013)
Allosteric inhibition of hypoxia inducible factor-2 with small molecules
Thomas H. Scheuermann et al.
NATURE CHEMICAL BIOLOGY (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
Haojian Zhang et al.
BLOOD (2012)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
HIF-1α protein is upregulated in HIF-2α depleted cells via enhanced translation
Kathrin Schulz et al.
FEBS LETTERS (2012)
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity
M. M. Reddy et al.
LEUKEMIA (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang et al.
CELL STEM CELL (2011)
Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism
Taro Hitosugi et al.
MOLECULAR CELL (2011)
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
Caroline Marty et al.
BLOOD (2010)
JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation
Seido Oku et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
Edwin Chen et al.
CANCER CELL (2010)
p21Waf1 is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate
V. S. Romanov et al.
CELL CYCLE (2010)
Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
Keiyo Takubo et al.
CELL STEM CELL (2010)
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis
Claudia Vener et al.
EXPERIMENTAL HEMATOLOGY (2010)
Roles of Hypoxia-Inducible Factor-1α (HIF-1α) Versus HIF-2α in the Survival of Hepatocellular Tumor Spheroids
Heidi Menrad et al.
HEPATOLOGY (2010)
The effects of molsidomine on hypoxia inducible factor alpha and Sonic hedgehog in testicular ischemia/reperfusion injury in rats
Ali Ihsan Dokucu et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2009)
The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors
Hiroshi Harada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells
Seung-Nam Jung et al.
CARCINOGENESIS (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
A gain-of-function mutation in the HIF2A gene in familial erythrocytosis
Melanie J. Percy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
JL Spivak
SEMINARS IN HEMATOLOGY (2004)
JunD reduces tumor angiogenesis by protecting cells from oxidative stress
D Gerald et al.
CELL (2004)
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF
S Wellmann et al.
LEUKEMIA (2004)
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
SO Ang et al.
NATURE GENETICS (2002)
分享论文
